Cargando…

Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients

Cytomegalovirus (CMV) viremia continues to cause significant morbidity and mortality in kidney transplant patients with clinical complications including organ rejection and death. Whole blood gene expression dynamics in CMV viremic patients from onset of DNAemia through convalescence has not been we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Richard, Schaenman, Joanna, Qian, Zachary, Pickering, Harry, Groysberg, Victoria, Rossetti, Maura, Llamas, Megan, Hoffmann, Alexander, Gjertson, David, Deng, Mario, Bunnapradist, Suphamai, Reed, Elaine F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634678/ https://www.ncbi.nlm.nih.gov/pubmed/34867983 http://dx.doi.org/10.3389/fimmu.2021.750659

Ejemplares similares

Plasma proteome perturbation for CMV DNAemia in kidney transplantation
por: Sigdel, Tara K., et al.
Publicado: (2023)

NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant
por: Pickering, Harry, et al.
Publicado: (2021)

629. Blood Transcriptome Variations Predict Infection and Rejection in the Older Kidney Transplant Recipient
por: Schaenman, Joanna, et al.
Publicado: (2018)

Differences in Proinflammatory Cytokines and Monocyte Subtypes in Older as Compared With Younger Kidney Transplant Recipients
por: Liang, Emily C., et al.
Publicado: (2018)

638. CMV-Specific T-Cell Immune Responses in Older vs. Younger Kidney Transplant Recipients
por: Liang, Emily, et al.
Publicado: (2018)

Differences in Gene Expression in Older Compared With Younger Kidney Transplant Recipients
por: Schaenman, Joanna M., et al.
Publicado: (2019)

Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor–Intolerant Patients
por: Schaenman, Joanna, et al.
Publicado: (2022)

DNA Methylation Age Is More Closely Associated With Infection Risk Than Chronological Age in Kidney Transplant Recipients
por: Schaenman, Joanna, et al.
Publicado: (2020)

2122. The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir
por: Srinivasan, Krithia, et al.
Publicado: (2022)

Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1–Infected Individuals
por: Aichelburg, Maximilian C., et al.
Publicado: (2015)

Adenovirus in a Kidney Transplant Recipient
por: Lum, Erik L., et al.
Publicado: (2023)

The TLR9 2848C/T Polymorphism Is Associated with the CMV DNAemia among HIV/CMV Co-Infected Patients
por: Jabłońska, Agnieszka, et al.
Publicado: (2021)

Genomic Markers Associated with Cytomegalovirus DNAemia in Kidney Transplant Recipients
por: Shapira, Guy, et al.
Publicado: (2023)

Spectrum of Coronavirus Disease 2019 Outcomes in Kidney Transplant Recipients: A Single-Center Experience
por: Lum, Erik, et al.
Publicado: (2020)

The risk of early and late cytomegalovirus DNAemia associated with Campath use in stem cell transplant recipients
por: Buyck, Hubertus C, et al.
Publicado: (2009)

934. Epidemiology and Outcomes of Epstein-Barr Virus DNAemia in Adult Solid Organ Transplant Recipients
por: Dong, Sara W, et al.
Publicado: (2021)

Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients
por: Baldanti, Fausto, et al.
Publicado: (2011)

Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients
por: Chang, Yeh-Chung, et al.
Publicado: (2022)

Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients
por: Gaber, A. Osama, et al.
Publicado: (2013)

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
por: Schulz, Uwe, et al.
Publicado: (2016)

2104. Cytomegalovirus DNAemia Patterns in Mismatched Solid Organ Transplant Recipients: A Retrospective Cohort Study.
por: Garcia, Oscar A Fernandez, et al.
Publicado: (2022)

The Detection of CMV in Saliva Can Mark a Systemic Infection with CMV in Renal Transplant Recipients
por: Waters, Shelley, et al.
Publicado: (2019)

Impact of CMV Blips in Transplant Recipients
por: Lodding, Isabelle Paula, et al.
Publicado: (2017)

Pretransplantation seroreactivity in kidney donors and recipients as a predictive factor for posttransplant BKPyV-DNAemia
por: Saláková, Martina, et al.
Publicado: (2022)

Renal Function and NODM in De Novo Renal Transplant Recipients Treated with Standard and Reduced Levels of Tacrolimus in Combination with EC-MPS
por: Chan, Laurence, et al.
Publicado: (2012)

BK Viremia Exacerbation With Adalimumab Coadministration
por: Lum, Erik L., et al.
Publicado: (2020)

Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity
por: Kirisri, Similan, et al.
Publicado: (2021)

CS15.1 CMV in transplant recipients
por: Tan, B.-H.
Publicado: (2011)

Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection
por: Bunnapradist, Suphamai, et al.
Publicado: (2021)

Effect of Concentration/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial
por: Suwelack, Barbara, et al.
Publicado: (2020)

Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
por: McBride, Jacqueline M, et al.
Publicado: (2019)

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
por: Diop, Ndeye Soukeyna, et al.
Publicado: (2021)

1750. Epidemiology of Cytomegalovirus DNAemia in Pediatric Solid-Organ Transplant Patients
por: Valencia Deray, Kristen, et al.
Publicado: (2019)

Does diabetes impact therapeutic immunomodulation therapy decisions for kidney transplant recipients? Data from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) trial
por: Weinrauch, Larry A, et al.
Publicado: (2017)

Stricturing CMV enteritis in an adult liver transplant recipient
por: Helmick, Ryan A, et al.
Publicado: (2019)

Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants
por: Jenkins, Meagan M., et al.
Publicado: (2023)

Human Herpesvirus 8 in Australia: DNAemia and Cumulative Exposure in Blood Donors
por: Speicher, David J., et al.
Publicado: (2022)

Increased EBV DNAemia after Anti-SARS-CoV-2 Vaccination in Solid Organ Transplants
por: Musialik, Joanna, et al.
Publicado: (2022)

1198. Measurement of Pre-transplant Anti-cytomegalovirus (CMV) Immunoglobulin G Titer to Predict Risk of CMV Infection in CMV-seropositive Kidney Transplant Recipients
por: Kirisri, Similan, et al.
Publicado: (2020)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
por: Kim, Jong Man, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fo289m9ihe117hae08mq7bncbg